Catecholamines induce long-lasting pro-inflammatory changes in monocytes in vitro and in vivo, indicating trained immunity. Charlotte van der Heijden and Niels Riksen, theme Vascular damage, and colleagues, contributed data to the understanding of pathways driving inflammatory changes in conditions characterized by high catecholamine levels, and propose that trained immunity underlies the increased cardiovascular event rate in PHEO patients. They have published their results in Circulation Research.
Exposure to high catecholamine levels is associated with inflammatory changes of myeloid cells and atherosclerosis, but the underlying mechanisms are only partly understood. To investigate whether the pro-inflammatory effects of noradrenaline and adrenaline can in part be explained by the induction of an immunological memory in innate immune cells, termed 'trained immunity'.
In vitro, they exposed human primary monocytes to (nor)adrenaline for 24 hours, after which cells were rested and differentiated to macrophages over 5 days. After restimulation with LPS on day 6, (nor)adrenaline-exposed cells showed increased TNF-α production. This coincided with an increase in glycolysis and oxidative phosphorylation measured with Seahorse technology on day 6 before restimulation. Inhibition of the β-adrenoreceptor-cAMP signaling pathway prevented the induction of training. In vivo, they studied the functional, transcriptional, and epigenetic impact of peak-wise exposure to high catecholamine levels on monocytes isolated from pheochromocytoma/paraganglioma (PHEO) patients. In PHEO patients (n=10), the peripheral blood cell composition showed a myeloid bias and an increase of the inflammatory CD14+CD16++ intermediate monocyte subset compared to controls with essential hypertension (n=14). Ex vivo production of pro-inflammatory cytokines was higher in PHEO patients. These inflammatory changes persisted for 4 weeks after surgical removal of PHEO. Transcriptome analysis of circulating monocytes at baseline showed various differentially expressed genes in inflammatory pathways in PHEO patients; epigenetic profiling of the promoters of these genes suggestsenrichment of the transcriptionally-permissive chromatin mark H3K4me3, indicative of in vivo training.
Catecholamines induce long-lasting pro-inflammatory changes in monocytes in vitro and in vivo, indicating trained immunity. Their data contribute to the understanding of pathways driving inflammatory changes in conditions characterized by high catecholamine levels, and propose that trained immunity underlies the increased cardiovascular event rate in PHEO patients.
Related news items
Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images22 May 2020
In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.read more
First clinical trial with genetically modified malaria vaccine completed22 May 2020
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.read more
New step in the development of a vaccine against malaria22 May 2020
A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.read more
Retirement of RIMLS Laboratory Assistant Nelly Mulders-Langen19 May 2020
After more than 45 years, Nelly said goodbye to "her" Radboudumc. We are going to miss her dedication and collegiality, but we wish her al the best for the future in good health.read more